Serum concentrations of clarithromycin and rifampicin in pulmonary Mycobacterium avium complex disease: long-term changes due to drug interactions and their association with clinical outcomes

BACKGROUND: Concomitant use of clarithromycin (CAM) and rifampicin (RFP) for the treatment of pulmonary Mycobacterium avium complex (MAC) disease affects the systemic concentrations of both drugs due to CYP3A4–related interactions. To date, however, there has been no report that investigates the lon...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Pharm Health Care Sci
Egile Nagusiak: Shimomura, Hitoshi, Andachi, Sena, Aono, Takahiro, Kigure, Akira, Yamamoto, Yosuke, Miyajima, Atsushi, Hirota, Takashi, Imanaka, Keiko, Majima, Toru, Masuyama, Hidenori, Tatsumi, Koichiro, Aoyama, Takao
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2015
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4728759/
https://ncbi.nlm.nih.gov/pubmed/26819743
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40780-015-0029-0
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak